Bluejay Diagnostics (BJDX) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $0.78, -1.02% vs the prior close of $0.79.
- Volume 88.00K shares, 0.0x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
BJDX dips 1.0% to $0.78. Closed at $0.78, -1.02% vs the prior close of $0.79. Day range $0.76–$0.78, opened at $0.77.
BJDX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — BJDX dips 1.0% to $0.78
- Closed at $0.78, -1.02% vs the prior close of $0.79. Day range $0.76–$0.78, opened at $0.77.
- Volume was 88.00K shares, 0.0x its 50-day average of 3.53M — lighter than usual.
- Price is -14.6% vs its 50-day average ($0.91) and -60.2% vs its 200-day average ($1.96).
- 52-week range $0.75–$14.00; today's close sits at 0% of that range, 94.4% below the 52-week high.
Oct 14, 2026 — BJDX slides 5.4% to $0.79
- Closed at $0.79, -5.41% vs the prior close of $0.83. Day range $0.77–$0.82, opened at $0.82.
- Volume was 75.10K shares, 0.0x its 50-day average of 4.00M — lighter than usual.
- Price is -14.6% vs its 50-day average ($0.92) and -60.0% vs its 200-day average ($1.97).
- 52-week range $0.75–$15.12; today's close sits at 0% of that range, 94.8% below the 52-week high.
Oct 13, 2026 — BJDX jumps 5.1% to $0.83
- Closed at $0.83, +5.05% vs the prior close of $0.79. Day range $0.78–$0.83, opened at $0.81.
- Volume was 335.00K shares, 0.1x its 50-day average of 4.00M — lighter than usual.
- Price is -10.2% vs its 50-day average ($0.93) and -57.9% vs its 200-day average ($1.98).
- 52-week range $0.75–$15.12; today's close sits at 1% of that range, 94.5% below the 52-week high.
- SEC filings that day: 8-K.
Oct 12, 2026 — BJDX slides 3.9% to $0.79
- Closed at $0.79, -3.88% vs the prior close of $0.82. Day range $0.76–$0.81, opened at $0.80.
- Volume was 139.30K shares, 0.0x its 50-day average of 4.00M — lighter than usual.
- Price is -14.7% vs its 50-day average ($0.93) and -60.2% vs its 200-day average ($1.99).
- 52-week range $0.75–$15.12; today's close sits at 0% of that range, 94.8% below the 52-week high.
Oct 9, 2026 — BJDX rises 1.0% to $0.82
- Closed at $0.82, +0.98% vs the prior close of $0.82. Day range $0.79–$0.83, opened at $0.81.
- Volume was 94.00K shares, 0.0x its 50-day average of 4.00M — lighter than usual.
- Price is -11.4% vs its 50-day average ($0.93) and -58.8% vs its 200-day average ($2.00).
- 52-week range $0.75–$16.68; today's close sits at 0% of that range, 95.1% below the 52-week high.
Oct 8, 2026 — BJDX rises 0.7% to $0.82
- Closed at $0.82, +0.74% vs the prior close of $0.81. Day range $0.79–$0.83, opened at $0.80.
- Volume was 93.50K shares, 0.0x its 50-day average of 4.00M — lighter than usual.
- Price is -12.4% vs its 50-day average ($0.93) and -59.4% vs its 200-day average ($2.01).
- 52-week range $0.75–$16.68; today's close sits at 0% of that range, 95.1% below the 52-week high.
Oct 7, 2026 — BJDX ends flat (-0.1%) to $0.81
- Closed at $0.81, -0.12% vs the prior close of $0.81. Day range $0.77–$0.84, opened at $0.79.
- Volume was 254.80K shares, 0.1x its 50-day average of 4.00M — lighter than usual.
- Price is -13.2% vs its 50-day average ($0.93) and -59.9% vs its 200-day average ($2.02).
- 52-week range $0.75–$16.68; today's close sits at 0% of that range, 95.1% below the 52-week high.
Oct 6, 2026 — BJDX jumps 6.6% to $0.81
- Closed at $0.81, +6.57% vs the prior close of $0.76. Day range $0.76–$0.84, opened at $0.78.
- Volume was 6.93M shares, 1.8x its 50-day average of 3.87M.
- Price is -13.4% vs its 50-day average ($0.94) and -60.2% vs its 200-day average ($2.04).
- 52-week range $0.75–$16.68; today's close sits at 0% of that range, 95.1% below the 52-week high.
- SEC filings that day: 8-K.
Oct 5, 2026 — BJDX slides 9.1% to $0.76, a 52-week low, 5 down days in a row
- Closed at $0.76, -9.08% vs the prior close of $0.84. Day range $0.75–$0.85, opened at $0.84.
- Volume was 393.90K shares, 0.1x its 50-day average of 3.87M — lighter than usual.
- Price is -19.3% vs its 50-day average ($0.94) and -62.9% vs its 200-day average ($2.05).
- 52-week range $0.75–$16.68; today's close sits at 0% of that range, 95.4% below the 52-week high.
- That makes 5 straight losses.
Oct 2, 2026 — BJDX dips 1.1% to $0.84, 4 down days in a row
- Closed at $0.84, -1.06% vs the prior close of $0.85. Day range $0.83–$0.85, opened at $0.85.
- Volume was 114.60K shares, 0.0x its 50-day average of 3.87M — lighter than usual.
- Price is -11.7% vs its 50-day average ($0.95) and -59.5% vs its 200-day average ($2.07).
- 52-week range $0.80–$16.68; today's close sits at 0% of that range, 95.0% below the 52-week high.
- That makes 4 straight losses.
BJDX latest news & SEC filings
Every SEC filing by or about BJDX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Oct 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 8, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 12, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$2.32M (prior year -$1.96M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$1.12 (prior year -$5.64) (loss narrowed vs Jun 30, 2025)
Jul 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade BJDX
- Last results release: May 7, 2026 (8-K Item 2.02). Previous ones: Mar 6, 2026, Nov 9, 2023, Aug 16, 2023. Based on that rhythm, the next report is likely around Aug 6, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.89% (largest 9.6%). That is a volatile stock.
- Liquidity: about 817.23K shares (≈$636.62K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.78 vs a range of $0.75–$14.00 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:4 on Jan 29, 2026, 1:50 on Nov 18, 2024
- Insider trades (Form 4, last 12 months, recent 25 shown): 6 open-market buys, 1 sales; latest: Financial Lp Hrt sold 34,938 shares on Jul 10, 2026.
- Latest filings: 8-K Oct 13, 2026; 8-K Oct 6, 2026; 8-K Sep 8, 2026.
- Share count: 4.47M shares outstanding (Aug 7, 2026), +199.0% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
BJDX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 0.77 | 0.78 | 0.76 | 0.78 | 88.00K |
| Oct 14, 2026 | 0.82 | 0.82 | 0.77 | 0.79 | 75.10K |
| Oct 13, 2026 | 0.81 | 0.83 | 0.78 | 0.83 | 335.00K |
| Oct 12, 2026 | 0.80 | 0.81 | 0.76 | 0.79 | 139.30K |
| Oct 9, 2026 | 0.81 | 0.83 | 0.79 | 0.82 | 94.00K |
| Oct 8, 2026 | 0.80 | 0.83 | 0.79 | 0.82 | 93.50K |
| Oct 7, 2026 | 0.79 | 0.84 | 0.77 | 0.81 | 254.80K |
| Oct 6, 2026 | 0.78 | 0.84 | 0.76 | 0.81 | 6.93M |
| Oct 5, 2026 | 0.84 | 0.85 | 0.75 | 0.76 | 393.90K |
| Oct 2, 2026 | 0.85 | 0.85 | 0.83 | 0.84 | 114.60K |
| Oct 1, 2026 | 0.86 | 0.87 | 0.83 | 0.85 | 59.50K |
| Sep 30, 2026 | 0.94 | 0.94 | 0.83 | 0.86 | 395.40K |
| Sep 29, 2026 | 0.96 | 0.97 | 0.93 | 0.94 | 264.80K |
| Sep 28, 2026 | 0.94 | 0.96 | 0.93 | 0.96 | 249.20K |
| Sep 25, 2026 | 0.95 | 0.96 | 0.91 | 0.92 | 286.30K |
| Sep 24, 2026 | 0.93 | 0.99 | 0.93 | 0.95 | 198.20K |
| Sep 23, 2026 | 0.94 | 0.97 | 0.90 | 0.97 | 736.60K |
| Sep 22, 2026 | 0.91 | 1.03 | 0.90 | 1.00 | 4.52M |
| Sep 21, 2026 | 0.93 | 0.94 | 0.90 | 0.91 | 214.40K |
| Sep 18, 2026 | 0.85 | 0.96 | 0.85 | 0.92 | 896.70K |
About Bluejay Diagnostics
Bluejay Diagnostics (BJDX) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in ACTON, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1704287.
BJDX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Donald R Chase | Director | Aug 18, 2026 |
| Indranil Dey | President and CEO | Aug 18, 2026 |
| Svetlana Dey | Director | Aug 18, 2026 |
| Douglas Clark Wurth | Director | Aug 18, 2026 |
| Fred S Zeidman | Director | Aug 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Indranil Dey | President and CEO | Aug 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 10, 2026 | Financial Lp Hrt | Sale | 34,938 | $1.40 |
| Jul 9, 2026 | Financial Lp Hrt | Buy | 64,047 | $1.51 |
| Mar 14, 2026 | Svetlana Dey | Buy | 12,500 | $2.00 |
| Mar 14, 2026 | Donald R Chase | Buy | 12,500 | $2.00 |
| Mar 14, 2026 | Fred S Zeidman | Buy | 12,500 | $2.00 |
| Mar 14, 2026 | Douglas Clark Wurth | Buy | 12,500 | $2.00 |
| Mar 14, 2026 | Indranil Dey | Buy | 12,500 | $2.00 |
BJDX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-6.85M | -15.25 | $-6.05M |
| Dec 31, 2024 | — | $-7.72M | -456.75 | $-7.82M |
| Dec 31, 2023 | — | $-9.95M | -3,631.48 | $-8.31M |
| Dec 31, 2022 | $249.04K | $-9.30M | -9.22 | $-7.74M |
| Dec 31, 2021 | — | $-3.49M | -0.41 | $-4.37M |
Latest balance sheet: total assets $11.53M, total liabilities $2.12M, cash $9.60M (as of Jun 30, 2026).
BJDX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| May 7, 2026 | 8-K Item 2.02 (results) | $1.82 |
| Mar 6, 2026 | 8-K Item 2.02 (results) | $1.86 |
| Nov 9, 2023 | 8-K Item 2.02 (results) | — |
| Aug 16, 2023 | 8-K Item 2.02 (results) | — |
| May 10, 2023 | 8-K Item 2.02 (results) | — |
| Mar 20, 2023 | 8-K Item 2.02 (results) | — |
| Nov 8, 2022 | 8-K Item 2.02 (results) | — |
| Jul 26, 2022 | 8-K Item 2.02 (results) | — |
| Apr 20, 2022 | 8-K Item 2.02 (results) | — |
| Mar 10, 2022 | 8-K Item 2.02 (results) | — |
| Dec 16, 2021 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Becton Dickinson (BDX)Medline (MDLN)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on BJDX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.